EP Patent

EP3260115A1 — Method for the production of a dosage form

Assigned to Omya International AG · Expires 2017-12-27 · 8y expired

What this patent protects

The present invention relates to a method for producing a dosage form, granules consisting of surface reacted calcium carbonate, and tablets and/or capsules obtained by the method, the use of a surface-reacted calcium carbonate in a such a method, a dosage form comprising the gra…

USPTO Abstract

The present invention relates to a method for producing a dosage form, granules consisting of surface reacted calcium carbonate, and tablets and/or capsules obtained by the method, the use of a surface-reacted calcium carbonate in a such a method, a dosage form comprising the granules, the use of the granules, or the tablets and/or capsules, or the dosage form in a pharmaceutical, nutraceutical, agricultural, cosmetic, home, food, packaging and personal care product as well as a pharmaceutical, nutraceutical, agricultural, cosmetic, home, food, packaging and personal care product comprising the granules, or the tablets and/or capsules, or the dosage form.

Drugs covered by this patent

Patent Metadata

Patent number
EP3260115A1
Jurisdiction
EP
Classification
Expires
2017-12-27
Drug substance claim
No
Drug product claim
No
Assignee
Omya International AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.